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A biochemical network can control 
formation of a synthetic material 
by sensing numerous specific 
stimuli
Ju Hun Yeon1, *, Karen Y. T. Chan1, *, Ting-Chia Wong1, Kelvin Chan1, Michael R. Sutherland2, 3, 
Rustem F. Ismagilov4, Edward L. G. Pryzdial2, 3 & Christian J. Kastrup1
Developing bio-compatible smart materials that assemble in response to environmental cues requires 
strategies that can discriminate multiple specific stimuli in a complex milieu. Synthetic materials 
have yet to achieve this level of sensitivity, which would emulate the highly evolved and tailored 
reaction networks of complex biological systems. Here we show that the output of a naturally 
occurring network can be replaced with a synthetic material. Exploiting the blood coagulation system 
as an exquisite biological sensor, the fibrin clot end-product was replaced with a synthetic material 
under the biological control of a precisely regulated cross-linking enzyme. The functions of the 
coagulation network remained intact when the material was incorporated. Clot-like polymerization 
was induced in indirect response to distinct small molecules, phospholipids, enzymes, cells, 
viruses, an inorganic solid, a polyphenol, a polysaccharide, and a membrane protein. This strategy 
demonstrates for the first time that an existing stimulus-responsive biological network can be used 
to control the formation of a synthetic material by diverse classes of physiological triggers.
Biological materials often form in a highly responsive manner, and organisms regulate these processes 
with precise control by integrating many environmental signals. This responsiveness is often the result of 
complex biochemical and genetic networks that sense numerous, diverse regulators1. These networks can 
amplify signals from appropriate stimuli with exquisite discretion. For example, the formation of blood 
clots is carefully controlled by a multitude of co-operative on- and off-switches. These switches regulate 
an intricate network of enzymatic reactions that polymerize and cross-link fibrin. Synthetic materials 
have not achieved this level of control1,2, partly because it is difficult to engineer numerous types of 
molecular recognition into the materials or their cross-linking systems. Current synthetic materials can 
typically only respond to one signal with high specificity3,4, or alternatively, many stimuli but with the 
inability to distinguish between similar signals5–7. For example, there are synthetic materials that form 
directly in response to a specific purified cross-linking enzyme8, but their formation lacks sensitivity to 
the plethora of stimuli that naturally controls the enzyme in its biological system. For this reason, there 
is tremendous interest in creating “smart” materials that are responsive to multiple signals, with a goal 
toward developing materials that can respond to environmental cues2. Many successful strategies have 
been developed1,9,10, but smart materials do not typically detect distinct stimuli from more than three to 
four diverse classes of signals2. It can be particularly challenging to control the formation of a material 
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through polymerization or self-assembly by multiple diverse stimuli, while the behaviour of the mate-
rial, such as swelling, degradation or localization, can more often be controlled5–7. We are unaware of 
a material whose formation is responsive to specific stimuli from over eight diverse classes of signals.
We asked the question: Can the responsiveness of a material be expanded if its cross-linking enzyme 
is connected to a biological network? To test this in proof-of-concept experiments for this strategy we 
used components that were previously well-characterized11–15. We used a synthetic material, a polyethyl-
ene glycol (PEG) hydrogel, whose polymerization is catalyzed by coagulation factor XIIIa (FXIIIa)11–15. 
FXIIIa is a transglutaminase that covalently cross-links glutamine to lysine residues or to other primary 
amines, and is a promiscuous enzyme with many known substrates. PEG macromers conjugated to 
appropriate peptides can be cross-linked by purified FXIIIa in buffered systems to form gels11–15. FXIIIa 
plays an important role in blood coagulation. During the coagulation process, the zymogen factor XIII 
(FXIII) is cleaved by the protease, thrombin, and activated to form FXIIIa, which then cross-links and 
stabilizes fibrin, the natural output of the coagulation system. In blood plasma, the activity of thrombin 
is controlled by a network of dozens of enzymatic reactions, which constitute a sensor that indirectly 
controls the activation of FXIII and cross-linking of fibrin16. We tested if this ability of the biological 
network to indirectly control cross-linking of fibrin could be used to control cross-linking of the syn-
thetic material, by mixing the synthetic macromer with fibrinogen-depleted plasma. By connecting these 
well-characterized components, we hypothesized that the biological network would allow the synthetic 
material to indirectly polymerize in a clot-like manner in response to new stimuli.
We found that this PEG hydrogel was formed as the end product of the coagulation cascade, in place 
of fibrin. Although the blood coagulation network is composed of dozens of reactions that could have 
potentially been impeded by replacing fibrinogen with high concentrations of a synthetic macromer, the 
network remained functional. The network retained the ability to sense the vast and specific repertoire 
of natural regulators of coagulation to robustly form and degrade this material. The material was then 
controlled not just by the direct addition of FXIIIa, or FXIII and thrombin, but also indirectly by the 
multitude of diverse stimuli that can modulate the coagulation network through thrombin and FXIIIa. 
The “biochemical network connected to the formation of a material” (BNC) polymerized the synthetic 
material in response to all of the system’s natural input triggers we evaluated, including specific chem-
icals, materials, cells, and combinations of stimuli. This BNC-material exhibited mechanical properties 
that were distinctly different from the biological network’s natural output of fibrin, such as greater stiff-
ness and structural stability. In this strategy, the responsiveness of the modified system emerged nearly 
entirely from the biological network and this responsiveness was passed on to the cross-linking enzyme 
and then indirectly to the material, leading to its clot-like polymerization. This approach of changing 
the output of a biological network resembles strategies used in synthetic biology, where networks in 
microorganisms are altered to produce new biological products or gain new functions17–19. Although the 
approach and the results are in some ways rather intuitive and expected, the outcome is remarkable in 
that it is the first liquid mixture we are aware of that responds to specific modulators from over eight 
diverse classes of signals to harden into a synthetic material.
Results
To test whether the coagulation network could exert control over the formation of a synthetic material 
that can be polymerized by FXIIIa, the PEG macromer and a polyamine were added to human plasma 
lacking fibrinogen, the soluble precursor of fibrin (Fig.  1a). This fibrinogen-deficient plasma enabled 
us to selectively detect gelling of the synthetic macromer, rather than fibrin. Purified FXIII zymogen 
was added due to co-depletion of FXIII along with fibrin. The synthetic macromer was constructed as 
described by others, by conjugating an 8-armed PEG to a peptide sequence found in α 2-antiplasmin, a 
natural, glutamine-donating, plasma protein substrate for FXIIIa20. Spermidine, a polyamine, was added 
with the synthetic macromer to fibrinogen-depleted plasma, serving as the amine-donating substrate for 
FXIIIa. Other polyamines could be substituted for spermidine (Supplementary Fig. S1). When blood 
coagulation was triggered with silica to activate the factor XII branch of the coagulation network, FXIIIa 
cross-linked the amine- and glutamine-donating substrates (spermidine and the α 2-antiplasmin peptides, 
respectively) polymerizing the BNC-material in a clot-like manner. The shear elastic modulus increased 
over 40-fold during formation. The BNC-material also displayed mechanical properties that differed 
from fibrin. Fibrin has a low elastic modulus and exhibits clot retraction, contracting to a fraction of 
its size when physically disturbed, which limits its use as a material for some applications. The shear 
elastic modulus of the BNC-material was over 10-fold higher than a fibrin clot (Fig. 1b,c). Furthermore, 
the BNC-material was more stable than fibrin, as it did not retract or permanently deform when han-
dled. Polymer formation in fibrinogen-deficient plasma occurred only when both the macromer and the 
amine-donating spermidine were present. An inhibitor of FXIIIa or a cocktail of serine protease inhibi-
tors prevented polymer formation, verifying that formation was indirectly controlled by the coagulation 
system. Using both conventional scanning electron microscopy (SEM) and cryo-SEM, the architecture 
of the BNC-material was compared to that of the synthetic polymer that was cross-linked with purified 
FXIIIa in the absence of plasma and other coagulation enzymes (Fig.  1d–i). The BNC-material better 
resembled the fibrous and porous structure of fibrin. This fibrous structure may have emerged from 
plasma proteins providing a template as the synthetic polymer formed, or from the spatial-heterogeneity 
of enzyme activation that occurs during coagulation21–24.
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Coagulation is responsive to several distinct classes of stimuli, including small organic molecules, 
divalent metal ions, the extracellular matrix, anionic lipid surfaces, and soluble and transmembrane pro-
teins. To test if the formation of the material indirectly responds to diverse stimuli when coupled to the 
coagulation network, its formation time was measured after adding known activators and inhibitors of 
coagulation. The activators included two enzymes, coagulation factor Xa and thrombin, thromboplastin 
(a mixture of transmembrane tissue factor (TF) embedded in phosphatidylserine (PS)/phosphatidylcho-
line (PC)-containing vesicles with CaCl2), and inorganic silica nanoparticles. The inhibitors included 
two small molecules, rivaroxaban and dansylarginine N-(3-ethyl-1,5-pentanediyl)amide HCl (DAPA), a 
small protein, hirudin, an enzyme, activated protein C, and a polysaccharide, fondaparinux. DAPA and 
hirudin bind and inhibit thrombin, rivaroxaban binds and inhibits FXa, APC is a proteolytic inhibitor of 
coagulation cofactors, and fondaparinux accelerates coagulation enzyme inhibition. These 9 diverse and 
specific modulators of coagulation significantly altered the formation time of the BNC-material. Clot-like 
polymerization occurred in 120 min in the absence of a stimulus, but occurred approximately twice as 
fast with an activator and significantly slower with an inhibitor (Fig.  2a,b). These same activators and 
inhibitors respectively sped up and slowed down fibrin clot formation in normal plasma (Supplementary 
Fig. S2). Although they influenced formation times, these modulators did not significantly affect the final 
material’s physical properties, such as the compressive elastic moduli (Supplementary Fig. S3). When the 
macromer was not coupled to the network, but was polymerized with purified FXIIIa alone, the stimuli 
did not cause significant differences in formation time (Fig. 2c). Thus, the original FXIIIa-cross-linkable 
material that was described previously could be made responsive to numerous new stimuli by connecting 
Figure 1. The biochemical reaction network of blood coagulation is a sensor that can be used to 
polymerize a synthetic material in a clot-like manner. (a) Schematic showing an input of activators 
(purple) into the coagulation enzyme network (blue) generating the cross-linker, FXIIIa, and a clot-like 
BNC-material (yellow) upon addition of the synthetic macromer. (b,c) Clot-like polymerization of liquid 
mixtures containing the coagulation network and either fibrin or the synthetic macromers. Images of 
microtubes (b) show clot-like gels adhered to pipette tips and pulled upwards when fibrin or the synthetic 
macromer was connected to the network. Gels did not form when inhibitors of coagulation enzymes 
were present. The gel formation times (blue bars) and shear elastic modulus (red bars) are shown in (c) 
Formation times are mean ± SEM with n = 3-5. (d–i) Scanning electron micrographs (top row) and cryo-
scanning electron micrographs (bottom row), of fibrin in normal plasma (d,g), the BNC-material (e,h) and 
macromer polymerized with FXIIIa but without the network (f,i) Scale bars represent 20 μ m.
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it to the coagulation network. The sensitivity of the BNC-material to activators could be modulated 
by changing the concentrations of coagulation factors (see supplementary methods and Table S1). By 
increasing the concentration of coagulation enzymes, another activator, ellagic acid, a plant polyphenol, 
could be detected by the BNC-material. The clot-like polymerization of the BNC-material was highly 
specific to its modulators and could distinguish between closely related signals (Fig. 2d–f). Prothrombin 
and factor X (the respective zymogens of thrombin and FXa), heat-inactivated thromboplastin, silica 
nanoparticles with hydroxlyated surfaces, and rutin (a plant polyphenol) have similar chemical structures 
to their counterparts, but led to significantly slower formation of the BNC-material. The enzymes of the 
coagulation system also specifically require calcium ions as opposed to other divalent cations, as forma-
tion of the material did not occur when calcium was replaced with magnesium or strontium.
The coagulation network can sense and respond to combinations of stimuli, which allow clotting 
to respond appropriately at sites of vascular damage without causing errant clotting and thrombosis. 
Sensing and responding to specific combinations of stimuli is challenging to engineer in synthetic 
materials. To evaluate if the network can be used to extend the repertoire of signals recognized by the 
original FXIIIa-cross-linkable material to include specific combinations of stimuli, the functional con-
tribution of thromboplastin constituents were dissected. Formation of the BNC-material was sensitive 
Figure 2. Clot-like polymerization of the BNC-material can be controlled by diverse and specific 
modulators when coupled to a network. (a,b) The formation times of the BNC-material in indirect 
response to known activators (a) or inhibitors (b) of coagulation, compared to the control without a 
stimulus. (c) The formation times without the network, using purified FXIIIa, did not respond to the 
modulators (all p > 0.05). (d–f) The formation times by activators compared to agents that have similar 
chemical structures, indicating that the formation of BNC-material was specific to its modulators. The 
formation of the BNC-material was selective to calcium ions (d) the active forms of coagulation enzymes (e) 
and contact pathway activators (f). (g) Schematic and graph showing that formation was indirectly sensitive 
to combinations of stimuli, and BNC-material formation was fastest when TF, PS and PC were combined 
together. All data indicate mean ± SEM, n = 3-5, *p < 0.05.
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to combinations of TF, PS, and PC, and only occurred when all three were combined (Fig. 2g), which is 
consistent with the sensitivity of the endogenous coagulation system.
Materials in nature can respond to subtle differences in the phenotypes of cells and viruses in their 
environments. We tested if formation of the BNC-material could distinguish between activated and 
non-activated peripheral blood mononuclear cells (PBMC). PBMC activate when treated with lipopol-
ysaccharide (LPS), a common bacterial antigen that induces the expression of TF. Formation of the 
BNC-material occurred faster in the presence of activated PBMC compared to resting PBMC that were 
not pre-stimulated by LPS (Fig. 3a). Formation in the presence of resting PBMC also occurred faster than 
without PBMC, but not as fast as with activated PBMC.
To further examine if the BNC-material retained the ability to detect minute changes in biological 
stimuli, two variants of herpes simplex virus (HSV) were compared, one with and one without host-cell 
derived TF incorporated in the envelope surface. HSV is a known stimulus of clotting if the host cell that 
replicates the virus expresses TF25. To produce the two variants of HSV, host cells that were otherwise 
identical were engineered to either express TF (TF+ ) or not express TF (TF-) and then were inoculated 
with HSV. The BNC-material detected this variation between the HSV and formed faster in the presence 
of the TF+ variant (Fig. 3b). It is remarkable that formation could detect the small difference between 
these two viruses, whose genotypes were identical but which were grown in host cells with or without 
a single gene knockout.
In contrast to solidification, there are many examples of synthetic materials that can be degraded in 
response to particular cells26,27. Peptide-containing materials, such as the synthetic macromer used in 
this report, are sensitive to degradation by proteases. In blood, fibrin is naturally degraded by the serine 
protease plasmin and bacterial proteases28, which can both degrade a wide range of peptides. We tested if 
the preformed BNC-material could also be degraded by plasmin or bacteria (Fig. 4a). The BNC-material 
was degraded by exogenous plasmin within 100 min, which was similar to fibrin gels formed under the 
same conditions (Fig. 4b). The synthetic gels formed in the absence of plasma degraded at a similar rate 
to those that contained plasma, suggesting that cleavage occurred at the synthetic peptides. Degradation 
of the BNC-material was sensitive to bacterial strains. Degradation was not apparent in the presence 
of two Staphylococcus strains, but did occur by, and could distinguish between, two strains of Bacilli 
(Fig. 4c). This could be due to differences in the type or concentration of proteases produced by these 
strains. In the future, altering the peptide sequences in the BNC-material presents potential for tuning 
the material’s mechanical and degradation properties for specific applications.
Discussion
Here, we demonstrate for the first time that a biological network can be used to control the forma-
tion of a synthetic material, allowing the material to then indirectly respond to specific stimuli from 
more than 8 diverse chemical and biological classes. Formation indirectly responded to even subtle 
changes in the overall phenotype of a virus. These proof-of concept experiments utilized well-known and 
well-characterized components; the biological network and sensor was the blood coagulation cascade 
from plasma, and the synthetic material was a FXIIIa-cross-linkable PEG macromer. Although with 
or without the biological sensor the materials were very similar after they were formed, the clot-like 
Figure 3. Cells and viruses with specific phenotypes can stimulate the BNC-material to polymerize in a 
clot-like manner. (a) The BNC-material formed faster when cells were stimulated with lipopolysaccharide 
(LPS), indicating sensitivity to the activation state of PBMC, *p < 0.05. (b) The formation of the BNC-
material could indirectly distinguish between two variants of herpes simplex virus (HSV), and formed faster 
when HSV containing TF on its surface was added as a stimulant compared to HSV that did not express TF. 
All data indicate mean ± SEM, n = 3.
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polymerization of the material was only modulated by diverse stimuli when the biological sensor was 
present. It is remarkable that the controllability over a synthetic polymer could reach a level of preci-
sion typically only seen in nature simply by mixing these well-characterized components together1,2. 
This approach mimics strategies used in synthetic biology, where microorganisms have been engineered 
to produce new molecules from their existing biological networks or to produce their metabolites in 
response to new stimuli17–19. The simple approach to extending the responsiveness of existing mate-
rials described here is different from approaches that chemically modify their backbones1. In fact, the 
responsiveness of the synthetic material was increased without requiring drastic changes to the chem-
ical composition of the final polymer. In the approach here, the material does not directly respond to 
multiple stimuli, but responds indirectly through a network and sensor that modulates its cross-linking 
agent. Specifically, modulators of the coagulation cascade primarily influence the rate of formation of 
FXIIIa rather than its catalytic efficiency29. It is expected that modifying the substrates and the catalytic 
activity30 would influence the magnitude of the formation times, but not the selectivity to the modulators. 
Modifying the polymer backbone, such as changing the length or branching of PEG, is expected to influ-
ence the physical properties of the final material31, but not the sensitivity of the system to the coagulation 
modulators. Strategically changing the polymer backbone to add recognition and sensitivity to other 
modulators, is a potential strategy for further increasing the responsiveness of the system13. Thus, smart 
materials based on polymers with responsive backbones could be complementary to the approach herein. 
The strategy described here is also distinguishable from, and potentially complementary to, approaches 
used to create functional materials through biomimicry. Biomimicry, imitating the dynamics and func-
tions of biological materials, is a proven strategy to engineer new and useful materials32,33. Together these 
approaches may be capable of creating multi-functional smart materials that emulate the highly evolved 
and tailored reaction networks of complex biological processes.
With further development, this specific BNC-material may have applications in medicine, arising 
from its ability to mimic aspects of fibrin/ogen and form in a clot-like manner in response to modu-
lators of coagulation. Blood clotting is a tightly-regulated process—normally activating only where and 
when it is supposed to. Retaining this regulation while replacing the output from a fibrin clot to a syn-
thetic material may be useful for developing smart tissue-adhesives. It may be particularly useful as an 
intravascular drug depot, where it could potentially be coated onto local areas of the vasculature with a 
catheter, as has been done with other gels in order to heal atherosclerotic plaques34. Alternatively, it may 
be useful in other applications. This tight biological regulation may allow it to be developed into a tool 
for detecting signals from specific cellular, viral, or bacterial pathogens that modulate clotting. Also, an 
appropriate synthetic equivalent of fibrin/ogen, developed based on the BNC-material strategy, would 
be useful for treating fibrinogen deficiency by replacing fibrin’s role in coagulating at vascular damage. 
Figure 4. The BNC-material was controllably degraded by specific modulators. (a) Schematic showing 
that the addition of a blood protease, plasmin, or bacteria degrades the BNC-material. (b) Plasmin degrades 
the BNC-material with or without fibrin present. (c) The material degraded in the presence of Bacilli strains, 
but not in the presence of Staphylococci strains. Data indicate mean ± SEM, n = 3, *P < 0.05.
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Fibrinogen deficiency can occur congenitally and acutely from trauma or sepsis, resulting in severe 
bleeding episodes35.
Although there are a number of potential applications, questions remain regarding the feasibility 
and extensibility of the BNC strategy. In theory, any biochemical cascade resulting in the output of a 
cross-linking enzyme, including other transglutaminases, can be exploited to exert biological control 
over the polymerization of synthetic materials bearing substrates for the enzyme. Furthermore, this strat-
egy can possibly be extended to biochemical cascades that do not produce cross-linking enzymes, such 
as those that produce proteases capable of activating the self-assembly of materials. A limitation of these 
strategies is that biological networks typically function under tightly controlled conditions, which may 
limit their use to specific biological settings. For example, although the coagulation network can function 
outside of blood vessels, applications of the BNC-material investigated here may be limited to the inside 
of blood vessels or to highly vascularized tissues. Identifying other biological networks that can modulate 
the activity of cross-linking agents or self-assembling processes36, and developing strategies that allow 
them to function outside their native environments is a potential route to reformulating useful synthetic 
materials to attain powerful new functions.
Methods
See supplementary information for a detailed description of the materials and methods.
Synthesizing and forming the BNC-material. A peptide sequence derived from α 2-antiplasmin, 
acetyl-NQEQVSPLTLLKKGC, was conjugated through its cysteine thiol to malemide groups on eight 
arms of branched PEG (Supplementary Fig. S4). In a buffered solution (10 mM HEPES, 7 mM sodium 
citrate, pH 7.4), the macromer (87 mg/mL) was polymerized in a reaction mixture containing human 
FXIIIa (3.7 μ M), spermidine (2.4 mM), DTT (0.90 mM), and CaCl2 (9.4 mM) (Supplementary Fig. S5). 
When the BCN-material was formed in plasma, the reaction mixture contained synthetic macromer 
(49 mg/mL), fibrinogen-deficient plasma (13.3% v/v), purified FXIII (0.29 μ M), spermidine (1.8 mM), 
DTT (0.66 mM), and CaCl2 (29 mM) in HEPES buffer. Plasmas deficient in fibrinogen and other factors 
were obtained from Affinity Biologicals. The reaction mixtures were incubated at 37 ⁰C with various 
concentrations of stimuli (Supplementary Table S2).
Measuring BNC-material formation. Thromboelastography (TEG) was used to determine the shear 
elastic moduli of the materials during formation (Supplementary Fig. S6). The BNC-material reaction 
mixture or normal plasma was recalcified and 300 μ L was monitored for 3 hr at 37 °C by TEG. The mate-
rials’ compressive elastic moduli were measured after formation by a controlled-force compression test 
(Supplementary Fig. S3). The BNC-material (5.79 μ L) was formed overnight at 37 °C, and its stress and 
strain were measured using a TA Q800 dynamic mechanical analyzer. The formation times in response 
to stimuli were measured in microwells using fluorescent beads added into the mixture (6 × 108 particles/
mL). The Brownian motion of fluorescent beads was monitored using an epi-fluorescence microscope, 
and cessation of movement indicated polymer formation. The microchambers were constructed using an 
adhesive silicone isolator sandwiched between two plastic coverslips, and each well held 5 μ L of the reac-
tion mixture or plasma (Supplementary Fig. S7). Degradation of the BNC-material or other preformed 
gels was measured by adding plasmin (333 μ g/mL) (Supplementary Table S3) or bacteria (36 μ g/mL) 
to samples formed in microchambers and measuring the time required to liberate trapped fluorescent 
beads. All p values were calculated by two-tailed Student’s-t test.
Isolation, Culture, and FACS Analysis of PBMC. PBMC were collected from human whole blood 
by a lymphocyte isolation density gradient and resuspended in culture medium (RPMI 1640; 50,000 U/L 
penicillin; 50 mg/L streptomycin; 25 mM HEPES; 20% FBS) at 106 cells/mL. Lipopolysaccharide (LPS) 
was added to cells at 1 μ g/mL. The cells were incubated at 5% CO2 and 37 ˚ C for 24 hr. Cells + /- LPS 
treatment were added to the BNC-material reaction mixture as a stimulus at a final concentration of 
1.3 × 105 cells/μ L. Remaining cells were stained with anti-Human CD142 PE and propidium iodide for 
FACS analysis (Supplementary Fig. S8).
Preparing TF+ HSV-1. A low-passage clinical isolate, HSV-1 NS, was propagated in human mel-
anoma cell line A7 that either expresses or is deficient in TF. Viral progeny were isolated by sucrose 
gradient ultracentrifugation25 and added to the BNC-material reaction mixture as an initiator.
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